Novel leukemic lymphoma with probable derivation from immature stage of natural killer (NK) lineage in an aged patient.
A 66-year-old male patient was admitted with dyspnea; physical examination revealed petechiae and systemic lymphadenopathy. Laboratory findings showed leukemia. The blasts in the peripheral blood were negative for cytochemical myeloperoxidase, and had condensed nuclear chromatin with a nucleolus. The histological diagnosis of the biopsied neck lymph node was lymphoblastic lymphoma. The leukemia cells expressed CD2, CD6, CD7, CD13low, CD56, beta chain of IL-2 receptorlow (IL-2R beta), and HLA-DR antigens, but not other pan-T (CD5, CD3, CD4, and CD8); pan-B (CD10, CD19, CD20, and CD24); natural killer (NK) (CD16, CD57); or myeloid (CD33) antigens. Electronmicroscopy revealed convoluted nuclei with conspicuous nucleoli and peripherally condensed heterochromatin. Membrane-bound granules containing an electron dense matrix were observed in the cytoplasm, indicating the NK cell nature of the neoplastic cells. While terminal deoxynucleotidyl transferase (TdT) and cytoplasmic CD3 were not detected by immunofluorescence on fixed smears, Northern blot analysis revealed the gene expression of CD3 epsilon, CD3 zeta, and TdT. Gene rearrangement analysis revealed that the beta, gamma, and delta chains of T-cell receptor (TCR) and immunoglobulin heavy chain (IgH) were of germline genotype. While the overall interpretation of the phenotype and genotype was difficult, the derivation of an immature stage of NK lineage was strongly suggested, based predominantly on the electronmicroscopic features. Despite initially successful chemotherapy, the patient died 14 months after initial presentation.
Kawano
S
S
Department of Laboratory Medicine, Kobe University School of Medicine, Japan.
Tatsumi
E
E
Yoneda
N
N
Yamaguchi
N
N
Goji
J
J
Ito
H
H
Nagai
T
T
Nishikori
M
M
Okamura
A
A
Koiwai
O
O
D000368:Aged; D000954:Antigens, Surface / Q000097:blood; D017252:CD3 Complex / Q000235:genetics; D004253:DNA Nucleotidylexotransferase / Q000235:genetics; D015870:Gene Expression; D015321:Gene Rearrangement; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000473:pathology*; D007938:Leukemia / Q000150:complications / Q000235:genetics / Q000473:pathology*; D007963:Leukocytes, Mononuclear / Q000737:chemistry / Q000473:pathology; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D008854:Microscopy, Electron; D010641:Phenotype; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000235:genetics / Q000473:pathology*; D012313:RNA / Q000097:blood / Q000235:genetics; D015375:Receptors, Interleukin-2 / Q000096:biosynthesis
D000954:Antigens, Surface; D017252:CD3 Complex; D007376:Interleukin-2; D015375:Receptors, Interleukin-2; D012313:RNA; D004253:DNA Nucleotidylexotransferase